Article
Molecular dynamic assisted investigation on impact of mutations in deazaflavin dependent nitroreductase against pretomanid: a computational study.
Journal of biomolecular structure & dynamics - 1 Jul 2023
Singh Ravi, Shaheer Muhammed, Sobhia M Elizabeth
Abstract excerpt
In the past decade, TB drugs belonging to the nitroimidazole class, pretomanid and delamanid, have been authorised to treat MDR-TB and XDR-TB. With a novel inhibition mechanism and a reduction in the span of treatment, it is now being administered in various combinations. This approach is not the ultimate remedy since the target protein Deazaflavin dependent nitroreductase (Ddn) has a high mutation frequency, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
